Bio

Clinical Focus


  • Pediatric Critical Care Medicine
  • Neurocritical Care

Academic Appointments


Administrative Appointments


  • Director Pediatric Neurocritical care, Critical Care Medicine (2018 - Present)

Boards, Advisory Committees, Professional Organizations


  • Co-Chair, Professional Practice Evaluation Committee. Lucile Packard Children?s Hospital, Stanford University (2018 - Present)
  • Appointed Committee Member, Post Graduate and Fellowship Education Committee, Society of Critical Care Medicine (SCCM) (2017 - Present)
  • Member, Society of Critical Care Medicine (SCCM) (2013 - Present)
  • Member, Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) (2016 - Present)
  • Member, Pediatric Neurocritical Care Research Group (PNCRG) (2016 - Present)
  • Member, Neurocritical Care Society (NCS) Pediatric Neurocritical Care Section (2018 - Present)
  • Member, Council on Child Abuse and Neglect (COCAN), American Academy of Pediatrics (2019 - Present)
  • Fellow, American Academy of Pediatrics (2017 - Present)

Professional Education


  • Medical Education: Medical College Of Wisconsin Office of Graduate Medical Education (2010) WI
  • Board Certification: American Board of Pediatrics, Pediatric Critical Care Medicine (2016)
  • Fellowship: Johns Hopkins University School of Medicine (2016) MD
  • Board Certification: American Board of Pediatrics, Pediatrics (2013)
  • Residency: Children's National Medical Center (2013) DC

Research & Scholarship

Current Research and Scholarly Interests


My research interests reside in the field of Neurocritical Care Medicine. My research focus has included inflammation following traumatic brain injury, outcome prediction after cardiac arrest, and neuro-monitoring in the pediatric intensive care setting. These interests are integrated clinically to focus on the merging of specialized neurologic monitoring and care with prognostic efforts in critically ill patients.

Publications

All Publications


  • Characteristics of Pediatric Extracorporeal Membrane Oxygenation Programs in the United States and Canada. ASAIO journal (American Society for Artificial Internal Organs : 1992) Troy, L., Su, F., Kilbaugh, T., Rasmussen, L., Kuo, T., Jett, E., Cornell, T., Berg, M., Haileselassie, B. 2020

    Abstract

    The aim of this study was to evaluate the current infrastructure and practice characteristics of pediatric extracorporeal membrane oxygenation (ECMO) programs. A 40-question survey of center-specific demographics, practice structure, program experience, and support network utilized to cannulate and maintain a pediatric patient on ECMO was designed via a web-based survey tool. The survey was distributed to pediatric ECMO programs in the United States and Canada. Of the 101 centers that were identified to participate, 41 completed the survey. The majority of responding centers are university affiliated (73%) and have an intensive care unit (ICU) with 15-25 beds (58%). Extracorporeal membrane oxygenation has been offered for >10 years in 85% of the centers. The median number of total cannulations per center in 2017 was 15 (interquartile range [IQR] = 5-30), with the majority occurring in the cardiovascular intensive care unit (median = 13, IQR = 5-25). Fifty-seven percent of responding centers offer ECPR, with a median number of four cases per year (IQR = 2-7). Most centers cannulate in an operating room or ICU; 11 centers can cannulate in the pediatric ED. Sixty-three percent of centers have standardized protocols for postcannulation management. The majority of protocols guide anticoagulation, sedation, or ventilator management; left ventricle decompression and reperfusion catheter placement are the least standardized procedures. The majority of pediatric ECMO centers have adopted the infrastructure recommendations from the Extracorporeal Life Support Organization. However, there remains broad variability of practice characteristics and organizational infrastructure for pediatric ECMO centers across the United States and Canada.

    View details for DOI 10.1097/MAT.0000000000001311

    View details for PubMedID 33181543

  • NAUSEA AND VOMITING AFTER CRANIOTOMY IN THE PEDIATRIC ICU: INCIDENCE AND VARIATIONS IN PRACTICE Chang, N., Duethman, L., Young, N., Rasmussen, L. LIPPINCOTT WILLIAMS & WILKINS. 2020
  • Infrastructure and Practice Characteristics of Pediatric ECMO Programs in the US and Canada Society of Critical Care Medicine Troy , L., Su, F., Berg, M., Rasmussen , L., Kuo, T., Jett, E., Jacobs, K., Haileselassie , B. 2019
  • INFRASTRUCTURE AND PRACTICE CHARACTERISTICS OF PEDIATRIC ECMO PROGRAMS ACROSS NORTH AMERICA Troy, L., Su, F., Berg, M., Rasmussen, L., Kuo, T., Jett, E., Jacobs, K., Haileselassie, B. LIPPINCOTT WILLIAMS & WILKINS. 2019
  • Trauma Bay Disposition of Infants and Young Children With Mild Traumatic Brain Injury and Positive Head Imaging Pediatric Critical Care Medicine Noje, C., Jackson, E., Nasr, I., Costabile, P., Cerullo, M., Hoops, K., Rasmussen, L., Henderson, E., Ziegfeld, S., Puett, L., Robertson , C. 2019
  • A Case Series of Parechovirus Encephalopathy: Apnea and Autonomic Dysregulation in Critically Ill Infants JOURNAL OF CHILD NEUROLOGY Ristagno, E. H., Bhalla, S. C., Rasmussen, L. K. 2018; 33 (12): 788?93

    Abstract

    This article aims to describe a rare cause of severe encephalitis in 2 cases of infants with signs of intracranial hypertension and severe autonomic dysregulation. The authors conclude that human parechoviruses are becoming a more recognized cause of encephalitis because of the increasing use of rapid detection methods. With early recognition of this clinical entity, improved care can be administered.

    View details for DOI 10.1177/0883073818789317

    View details for Web of Science ID 000444976000007

    View details for PubMedID 30105932

  • Traumatic Injury Leads to Inflammation and Altered Tryptophan Metabolism in the Juvenile Rabbit Brain JOURNAL OF NEUROTRAUMA Zhang, Z., Rasmussen, L., Saraswati, M., Koehler, R. C., Robertson, C., Kannan, S. 2019; 36 (1): 74?86
  • Neurocritical Care for Severe Pediatric Traumatic Brain Injury Rasmussen, L., Raghupathi, R., Lang Chen , S., Huh, J., Su, F. Medscap Drugs and Diseases. 2018
  • Albuterol Use in Children Hospitalized with Human Metapneumovirus Respiratory Infection INTERNATIONAL JOURNAL OF PEDIATRICS Rasmussen, L. K., Schuette, J., Spaeder, M. C. 2016: 7021943

    Abstract

    Introduction. Human metapneumovirus (HMPV) is a paramyxovirus from the same subfamily as respiratory syncytial virus (RSV) and causes similar acute lower respiratory tract infection. Albuterol in the setting of acute RSV infection is controversial and has not yet been studied in HMPV. We sought to determine the frequency of albuterol use in HMPV infection and the association between albuterol administration and patient outcomes. Methods. We conducted a retrospective cohort study identifying all patients hospitalized in a tertiary care children's hospital with laboratory-confirmed HMPV infection between January 2010 and December 2010. Results. There were 207 patients included in the study; 57% had a chronic medical condition. The median hospital length of stay was 3 days. Only 31% of patients in the study had a documented wheezing history, while 69% of patients received at least one albuterol treatment. There was no difference in length of stay between patients who received albuterol and those who did not. Conclusion. There is a high frequency of albuterol use in children hospitalized with HMPV infection. As with RSV, evidence may not support routine use of bronchodilators in patients with acute HMPV respiratory infection. Research involving additional patient outcomes and illness severity indicators would be useful in future studies.

    View details for PubMedID 26925109

    View details for PubMedCentralID PMC4748140

  • PERIPHERAL IMMUNE RESPONSE AFTER PEDIATRIC TRAUMATIC BRAIN INJURY IN RABBIT Rasmussen, L., Zhang, Z., Saraswati, M., Kannan, S., Robertson, C. MARY ANN LIEBERT, INC. 2015: A88

Footer Links:

Stanford Medicine Resources: